It would be very interesting here on Monday. With the latest update from WHO regarding Antibody test, some investors from ODX may buy NCYT to recoup their losses imho. Gl
Still the market cap is very low. We also have a product that is a biomarker for lung diseases and the sales is increasing every year especially now during this pandemic time imho. Gl